Telehealth General Psychiatry Prescribing: What Prescribers Can Do in Illinois

If you’re a psychiatrist or PMHNP wondering what you can actually prescribe through telehealth, you’re not alone. The rules around remote prescribing — especially controlled substances like Adderall, Xanax, or Suboxone — have changed dramatically since 2020, and keeping up with federal waivers, state exceptions, and collaborative practice requirements feels like a full-time job.

Here’s the reality: Yes, psychiatrists can prescribe nearly all psychiatric medications through telehealth in 2026, including Schedule II stimulants and benzodiazepines, thanks to extended federal flexibilities. But the details matter — your state, your provider type (MD vs PMHNP), and even which insurance you bill can all affect what you can do.

This guide cuts through the confusion. We’ll cover what psychiatrists and PMHNPs are legally allowed to prescribe via telemedicine, how state laws differ (especially in California, Texas, Florida, New York, Pennsylvania, and Illinois), what the current federal rules say about controlled substances, and what reimbursement looks like for telehealth medication management.

What Psychiatrists Can Prescribe Via Telehealth (Federal Rules)

As a fully licensed physician, a psychiatrist has broad prescriptive authority in all 50 states. The question isn’t what you can prescribe — it’s how you establish the patient relationship and comply with controlled substance laws when doing it remotely.

Valid Patient-Physician Relationship

Every state requires a legitimate clinical relationship before you write a prescription. The good news: telehealth counts as a valid encounter in virtually every state, as long as it meets the standard of care.

Most states define this as a real-time audio-visual interaction that allows the same level of assessment as an in-person visit. Texas law, for example, explicitly states that a telemedicine encounter using two-way audio-video communication satisfies the examination requirement for prescribing. Same goes for Florida, California, New York, Pennsylvania, and Illinois.

Practically, this means: You can see a new patient via secure video, conduct a thorough psychiatric evaluation, and prescribe medications after that initial virtual visit — no in-person requirement under most state laws (with controlled substances being the one area of nuance we’ll get to).

Controlled Substances: The Ryan Haight Act & Current Federal Waivers

Here’s where it gets interesting. Federally, the Ryan Haight Act historically required at least one in-person medical evaluation before prescribing controlled substances (Schedules II–V). This was a major barrier for telepsychiatry treating ADHD, anxiety disorders, and opioid use disorder.

But since March 2020, that requirement has been temporarily waived under federal public health emergency powers. As of February 2026, the DEA has extended these telemedicine flexibilities through December 31, 2025 (with expectations of further extensions or permanent rule changes).

What this means for you right now:

• You can prescribe Schedule II stimulants (Adderall, Ritalin, Vyvanse) to new ADHD patients via video visit, without an initial in-person exam
• You can initiate buprenorphine for opioid use disorder via telehealth (the X-waiver requirement was also eliminated in 2023, simplifying this further)
• You can prescribe benzodiazepines, sleep medications, and other controlled substances for psychiatric treatment through telemedicine

This applies nationwide, to all psychiatrists, under the current federal waiver.

The catch: The DEA has proposed new rules that could reimpose some in-person requirements or create special registration systems for telemedicine prescribing. These proposals have been delayed multiple times — most recently pushed to late 2024 for finalization. Many expect the DEA will either maintain the flexibilities permanently (with guardrails like 30-day supply limits for initial prescriptions) or create a hybrid system where providers can prescribe via telehealth if the patient was referred by an in-person clinician.

Bottom line: Stay alert for DEA rule changes, but for now, you’re operating under significant flexibility to manage psychiatric medications remotely.

State-Level Controlled Substance Rules

While federal law sets the floor, some states have additional restrictions or explicit permissions for teleprescribing controlled substances:

Florida: One of the most permissive. Florida law specifically allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders (Florida Statutes 456.47). The only prohibition is for chronic non-malignant pain management. A Florida-licensed psychiatrist can initiate ADHD stimulants or anti-anxiety medications in a telemedicine visit for a Florida patient — this is explicitly permitted.

Texas: Generally allows telemedicine prescribing if the standard of care is met, but prohibits teleprescribing opioids for chronic pain (requires in-person exam). Mental health treatment is exempt from this restriction. A Texas psychiatrist can prescribe stimulants or benzodiazepines via telehealth under the federal waiver — the state doesn’t add barriers beyond requiring a valid video encounter. Texas also mandates checking the state Prescription Monitoring Program (PMP) before prescribing any controlled substance.

New York: Recently updated its rules (mid-2025) to explicitly align with federal telehealth allowances. New York now permits controlled substance prescribing via telemedicine when consistent with federal law. The state removed a previous in-person exam requirement that had been suspended under emergency orders. NY psychiatrists can continue teleprescribing under the DEA waiver without state-level non-compliance issues.

California: Requires a ‘good faith exam’ prior to prescribing, but explicitly permits this exam to be done via telehealth. California defers to federal law on controlled substances; during the federal waiver period, CA psychiatrists have been prescribing stimulants and other controlled medications to new patients via telemedicine. California does require enrollment in CURES (the state PMP) and checking it before prescribing Schedule II–IV drugs.

Pennsylvania & Illinois: Both default to federal rules for controlled substance teleprescribing. Neither adds state-level barriers beyond standard prescribing requirements (like PMP checks). Psychiatrists in these states can prescribe psychiatric controlled substances via telehealth under current federal allowances.

PMP (Prescription Monitoring Program) Requirements

Regardless of telehealth vs in-person, most states require checking the state PMP database before prescribing controlled substances. This applies equally to telemedicine:

• Texas, New York, California, Florida, Pennsylvania, and Illinois all have mandatory PMP check laws
• Frequency varies: some states require checking for every controlled prescription, others allow checking once every 3–4 months for ongoing patients
• Telehealth platforms like Klarity often integrate PMP access into their EMR systems to streamline this

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP Prescribing Authority: How It Differs from Psychiatrists

This is where things get complex. Psychiatrists have universal prescribing authority and independence. PMHNPs operate under a patchwork of state-specific rules that can significantly limit what they can do — especially in telehealth.

The Three Categories of NP Practice Authority

Full Practice Authority (FPA) States: NPs can practice independently, assess and diagnose patients, and prescribe medications (including Schedules II–V) under their own license and DEA registration. No physician collaboration required.

As of 2025, approximately 34 states have Full Practice Authority for NPs, including recent additions like Massachusetts (2021), Kansas (2022), Indiana (2023), Louisiana (2024), and Michigan (2025).

In FPA states, a PMHNP can manage ADHD medications, prescribe benzodiazepines, and run their own telehealth practice just like a psychiatrist (though reimbursement may differ — more on that below).

Reduced Practice States: NPs have some independence but need a collaborative agreement with a physician for certain aspects of care, usually prescribing. The NP can diagnose and treat, but medication authority requires a written agreement with a supervising physician.

Examples: New York, Illinois, California (transitioning), Pennsylvania

These states often have ‘transition to independence’ periods — NPs start with required collaboration, then after accumulating supervised hours (2–4 years), they can practice independently.

Restricted Practice States: NPs must practice under continuous physician supervision for all patient care activities. Prescribing requires explicit physician delegation, and there’s no pathway to independence.

Examples: Texas, Florida (for psychiatric NPs), Tennessee, Alabama

In these states, a PMHNP essentially cannot practice solo or prescribe without a physician’s oversight — they function more as physician extenders.

State-by-State Breakdown for PMHNPs

California: Transitioning to FPA via AB 890 (2020). As of 2023, NPs with ≥3 years experience can become ‘103 NPs’ and practice without physician supervision in group settings. By January 2026, they can apply for ‘104 NP’ status allowing full independent practice even outside group settings. New graduate NPs still need physician-supervised standardized procedures for their first 3 years.

Texas: Restricted. All NPs must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. There’s no pathway to independent practice regardless of experience. Additionally, Texas NPs cannot prescribe Schedule II controlled substances in outpatient settings except in very limited circumstances (terminal illness, emergencies). Many Texas PMHNPs cannot independently prescribe ADHD stimulants — the collaborating physician typically writes those prescriptions. The state caps one physician to supervising 7 NPs/PAs at a time.

Florida: Restricted for psychiatric NPs. Florida’s 2020 autonomous practice law (HB 607) applies only to primary care NPs (family medicine, internal medicine, pediatrics). Psychiatric NPs were excluded and still require a supervising physician. A PMHNP in Florida must practice under a protocol with a psychiatrist collaborator. However, Florida does allow psychiatric NPs to prescribe controlled substances (including >7 day supplies of Schedule II psychotropics) when treating mental illness — they just need the collaboration agreement in place.

New York: Reduced → FPA after experience. New NPs must practice under a written collaborative agreement with a physician for their first 3,600 hours (roughly 2 years). After accumulating those hours, they can practice independently without a written agreement or supervision — they just need an informal ‘collaborative relationship’ (attestation of having physician contacts for referral). In effect, experienced NY PMHNPs have full practice authority.

Pennsylvania: Reduced (no FPA pathway yet). All NPs must maintain a collaborative agreement with a physician indefinitely. The agreement specifies which drugs the NP can prescribe. PA NPs can prescribe Schedules II–V if delegated, but Schedule II prescriptions are limited to 30-day supply and require notifying the physician within 24 hours. Physicians must review a portion of NP charts regularly (often 10% every 3 months). Legislation for FPA has been proposed but not passed as of 2026.

Illinois: Reduced → FPA after transition. NPs must complete 4,000 hours of clinical practice under physician collaboration plus 250 hours of continuing education in advanced pharmacology. After meeting these requirements, they can apply for Full Practice Authority and prescribe independently, including controlled substances. Until FPA is granted, NP prescriptions must be under physician delegation (the physician’s name appears on scripts).

Collaborative Practice Agreements: What PMHNPs Need to Know

In states requiring collaboration, the agreement typically includes:

Scope Definition: What conditions the NP can treat, which medications they can prescribe, any exclusions (e.g., ‘NP will not prescribe ADHD stimulants to children under 12’ or ‘no buprenorphine prescribing without psychiatrist consultation’)

Physician Availability: Requirement that the collaborating physician is available for consult (usually by phone), with specified response times

Chart Review: Many states mandate the physician review a percentage of NP charts monthly or quarterly (e.g., South Carolina requires 10% monthly, Tennessee requires periodic on-site visits)

Specialty Match: Some states (like Florida and Pennsylvania) require the collaborating physician to be in the same specialty. For psychiatric NPs, this often means finding a psychiatrist collaborator — which can be challenging in underserved areas and typically incurs a fee (many psychiatrists charge $1,000–3,000/month to serve as a collaborator)

Filing Requirements: Some states require filing the agreement with the state nursing board or medicine board, with updates whenever the NP changes practice sites or the physician changes

Pain Points for PMHNPs:

• Finding a collaborator in restricted states can delay your ability to practice
• Cost of collaboration fees affects your net income
• Administrative burden of maintaining agreements, especially when practicing across multiple states in telehealth
• Scope limitations — even in collaborative states, the physician can restrict your prescribing more narrowly than state law allows

Reimbursement Differences: MD vs NP

Even when PMHNPs have similar legal authority, reimbursement often differs:

Medicare reimburses nurse practitioners at 85% of the physician fee schedule when billed under the NP’s own NPI. For a 15-minute med check (99213), a psychiatrist gets ~$95, an NP gets ~$81.

Many private insurers follow a similar approach (85–90% of physician rates), though some states have passed equal reimbursement laws (Nevada, Maryland). The trend is toward parity, but it’s not universal.

Medicaid programs vary — some pay NPs the same as MDs, others pay less.

For a telehealth practice, this means revenue per visit may differ by 10–15% depending on whether the patient sees an MD or NP. Some practices address this through ‘incident-to’ billing (billing NP services under a supervising physician’s NPI) in office settings, but this doesn’t apply to telehealth under current Medicare rules.

Medication Management Reimbursement: What to Expect for Telehealth Visits

Understanding payment is crucial for practice sustainability. Here’s what psychiatric medication management pays through various channels in 2026:

Common Billing Codes

Initial Evaluation: CPT 90792 (Psychiatric Diagnostic Evaluation with Medical Services) — 60-minute initial consult

• Medicare pays approximately $173 nationally
• Private insurance typically $200–300 depending on region

Follow-Up Medication Checks: Standard E/M codes

• 99213 (15-minute, straightforward): Medicare ~$95, commercial $130–150
• 99214 (25-minute, moderate complexity): Medicare ~$136, commercial $180–220
• 99215 (40-minute, high complexity): Medicare ~$192, rarely used for routine med checks

Add-On Psychotherapy Codes: If you’re doing therapy + med management in the same visit:

• 90833 (30 min add-on): adds ~$80 to the E/M
• 90838 (60 min add-on): adds ~$135 to the E/M

Telehealth Parity

The good news: telehealth is basically integrated now. Medicare and most state laws require payment parity for behavioral health services delivered via telehealth.

Medicare: Permanently allows telehealth for mental health services (with a technical requirement of one in-person visit every 6–12 months that’s currently paused through 2025). You bill the same E/M codes for video visits and get paid as if it were in-person, using place-of-service code 02 or modifier -95.

Private Insurance: Over half of states have payment parity laws for tele-mental health:

• Illinois mandates equal reimbursement through 2027 (SB 667)
• California requires payment parity (AB 744)
• New York, Pennsylvania, Florida all expanded telehealth coverage, though parity provisions vary

Texas doesn’t mandate payment parity by law, but most insurers voluntarily pay equal rates for tele-mental health due to high demand.

Audio-Only Exception: Medicare and some state Medicaid programs now reimburse for audio-only telehealth for mental health (for patients without video access), at the same rate as office visits. This flexibility was extended through 2024 and likely continues.

Medicaid & Public Payers

Medicaid rates tend to be lower than Medicare/commercial (often 60–75% of Medicare rates), but many states have enhanced behavioral health payments:

• New York Medicaid reimburses tele-mental health at the same rate as face-to-face
• Pennsylvania Medicaid expanded telehealth permanently with parity
• California Medi-Cal has invested in raising behavioral health reimbursement recently

Collaborative Care Model (CoCM)

For psychiatrists working in consultative models (where you advise primary care teams managing psych meds), there are specific monthly payment codes:

• 99492 (first month): Medicare pays ~$161/month per patient
• 99493 (subsequent months): ~$130/month per patient

New York and Washington Medicaid also reimburse CoCM codes. This is relevant if you’re consulting to primary care rather than doing direct patient visits.

Real-World Revenue Expectations

Example Practice Economics:

A psychiatrist doing 15-minute med checks via telehealth:

• 4 patients/hour × $95 Medicare (or $140 commercial average) = $380–560/hour
• 20 clinical hours/week = $7,600–11,200/week
• Annual gross revenue potential: $395,000–580,000

A PMHNP with similar volume (at 85% reimbursement):

• $335,000–495,000 annual gross

These are gross figures before overhead (platform fees, malpractice, admin staff, etc.), but they illustrate why psychiatric medication management via telehealth is economically viable.

The Economics of Building a Psychiatric Telehealth Practice: DIY Marketing vs Platforms

Here’s where many providers get stuck: how do you actually get patients?

The DIY Marketing Reality

You’ll see a lot of advice online about ‘growing your own practice’ through SEO, Google Ads, or directory listings. Let’s be honest about what that actually costs:

SEO (Search Engine Optimization):

• Timeline: 6–12 months before you see meaningful patient flow
• Costs: $2,000–5,000/month for professional SEO (content, backlinks, technical optimization)
• Reality: Most solo providers don’t have the expertise or patience. You’re competing against established practices and aggregators with bigger budgets.

Google Ads (PPC):

• Cost per click: $15–40+ for mental health keywords like ‘psychiatrist near me’ or ‘ADHD medication’
• Conversion rate: Typically 2–5% from click to booked appointment
• Real cost per booked patient: $200–400+ (and that’s before accounting for no-shows from cold leads)
• Monthly spend to generate decent volume: $3,000–8,000

Directory Listings (Psychology Today, Zocdoc):

• Psychology Today: $29.95–49.95/month for a profile where you compete with hundreds of other providers on the same search page
• Zocdoc: Charges per booking ($35–100+ per patient) PLUS monthly subscription fees
• Total monthly cost for multi-directory presence: $200–500+, with uncertain conversion

All-in DIY Marketing Cost:

When you factor in all the expenses — agency/consultant fees, ad spend testing and optimization, staff time to handle and qualify leads, no-show rates from unqualified leads, months of investment before results — acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ per patient.

And that’s if you execute well. Many providers spend $5,000–10,000/month for 6+ months with minimal results before they figure out what works.

The Platform Model: Klarity Health’s Approach

This is where a platform like Klarity makes economic sense. Instead of gambling on marketing channels, you pay only when a qualified patient books with you.

How it works:

• Pay-per-appointment model (similar to Zocdoc): You pay a standard listing fee per new patient lead
• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs like Doxy.me or SimplePractice)
• Both insurance and cash-pay patient flow managed through the platform
• You control your schedule — only pay when you see patients

The economic value:

Instead of spending $3,000–5,000/month on marketing with uncertain ROI, you pay a known cost per patient acquisition with guaranteed qualified leads. No wasted ad spend on clicks that don’t convert. No staff time chasing cold leads.

If the platform fee is, say, $150 per new patient, and that patient stays for an average of 6 visits (typical for med management), your true acquisition cost is $25 per visit — far better economics than DIY marketing, especially when you’re starting out or scaling.

For providers in restricted-practice states (like Texas or Florida PMHNPs who need collaborative agreements), platforms like Klarity can also provide the physician oversight infrastructure, removing another barrier to entry.

State-Specific Telehealth & Prescribing Summary

Here’s a quick reference for the priority states:

California

Psychiatrists: Full independent prescribing. Telehealth exam satisfies ‘good faith exam’ requirement.

PMHNPs: Transitioning to independence. Experienced NPs (3+ years) can practice independently in group settings now (103 NP), and by January 2026 can apply for full solo independence (104 NP).

Controlled Substances: Permitted via telehealth under federal waiver. Must check CURES (state PMP) before prescribing Schedule II–IV.

Telehealth Payment: Private payer parity mandated (AB 744).

Market: High demand — 11+ million Californians in mental health shortage areas. Provider-to-population ratio ~1:5,000.

Texas

Psychiatrists: Full independent prescribing. Can prescribe psychiatric controlled substances via telehealth. Prohibited from teleprescribing Schedule II opioids for chronic pain.

PMHNPs: Restricted. Must have Prescriptive Authority Agreement with physician. Cannot prescribe Schedule II controlled substances in outpatient settings (except limited exceptions). One physician can supervise max 7 NPs.

Controlled Substances: Must check Texas PMP. Federal waiver allows psychiatric controlled substance teleprescribing for psychiatrists. NPs face state limitations beyond federal rules.

Telehealth Payment: Coverage required but no mandated parity (most insurers voluntarily pay equal rates for mental health).

Market: Severe shortage — 1:8,500 provider-to-population ratio. 380 mental health shortage areas needing 614 psychiatrists.

Florida

Psychiatrists: Full independent prescribing. Florida explicitly permits controlled substance prescribing via telehealth for psychiatric treatment (FS 456.47).

PMHNPs: Restricted. Psychiatric NPs excluded from autonomous practice law. Must practice under psychiatrist supervision. Can prescribe controlled substances (including >7 days of Schedule II psychotropics for mental illness) with collaboration agreement in place.

Controlled Substances: State law carves out psychiatric treatment as exception to general telehealth prescribing restrictions.

Telehealth Payment: No parity mandate; voluntary insurer coverage.

Market: High demand — 1:9,000 provider-to-population ratio. ~7.8 million Floridians in shortage areas.

New York

Psychiatrists: Full independent prescribing. NY updated rules (2025) to align with federal telehealth controlled substance allowances.

PMHNPs: Must practice under collaborative agreement for first 3,600 hours (≈2 years). After that, can practice independently without supervision.

Controlled Substances: NY permits controlled substance teleprescribing consistent with federal law. Removed state-level in-person requirement. Must check I-STOP (PMP) database.

Telehealth Payment: Strong parity — all insurers must cover telehealth for mental health.

Market: Best provider density (1:2,900 statewide), but upstate regions still undersupplied. 197 shortage areas needing ~230 psychiatrists.

Pennsylvania

Psychiatrists: Full independent prescribing.

PMHNPs: Reduced practice. Must maintain collaborative agreement indefinitely (no FPA pathway yet). Can prescribe Schedule II–V with delegation, but Schedule II limited to 30-day supply with physician notification within 24 hours. Physician must review portion of charts regularly.

Controlled Substances: Defaults to federal rules for teleprescribing.

Telehealth Payment: No comprehensive parity statute yet (efforts ongoing). Medicaid and many insurers cover at parity.

Market: Mid-level density (1:4,600 ratio). Rural central PA has significant shortages.

Illinois

Psychiatrists: Full independent prescribing.

PMHNPs: Must complete 4,000 hours + 250 CE hours under physician collaboration, then can apply for Full Practice Authority for independent practice including controlled substance prescribing.

Controlled Substances: NPs with FPA get own controlled substance registration. Without FPA, limited delegation (30 days for Schedule II).

Telehealth Payment: Mandated parity through 2027 (SB 667).

Market: 1:5,800 ratio. ~291 providers needed to eliminate shortages.

FAQ: Psychiatric Prescribing Through Telehealth

Can psychiatrists prescribe Adderall or other ADHD stimulants via telehealth?

Yes. Under current federal DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II stimulants like Adderall, Ritalin, or Vyvanse to new patients via telehealth without an initial in-person exam. This applies nationwide. State laws in CA, TX, FL, NY, PA, and IL all permit this under the federal allowance. You must establish a valid patient-physician relationship via video (audio-visual exam) and check your state’s prescription monitoring database.

Can PMHNPs prescribe controlled substances through telemedicine?

It depends on the state. In Full Practice Authority states (like Arizona, Oregon, Washington), yes — PMHNPs can prescribe controlled substances via telehealth just like psychiatrists, under their own DEA registration. In restricted states like Texas, PMHNPs face significant limitations (cannot prescribe Schedule II in outpatient settings). In transitional states like New York or Illinois, experienced NPs (after 3,600–4,000 hours) gain independent prescribing authority. In Florida, psychiatric NPs need a psychiatrist collaborator but can prescribe psychotropic controlled substances with proper delegation.

Do I need to see patients in person before prescribing medication via telehealth?

For most psychiatric medications: No, as long as you conduct a thorough telehealth evaluation (video visit that meets standard of care). For controlled substances: Currently no, thanks to federal DEA waivers through December 2025. However, this could change if the DEA finalizes new rules — stay alert for updates. Some states may have additional requirements (e.g., Medicare’s future requirement of one in-person visit every 6–12 months for mental health patients, though currently paused).

What medications can psychiatrists NOT prescribe through telehealth?

There are very few absolute prohibitions for psychiatrists. The main restrictions are around chronic pain management with opioids (some states like Texas prohibit teleprescribing opioids for long-term pain, though psychiatric use is typically exempt). Clozapine requires REMS program enrollment (not a telehealth-specific restriction). Otherwise, psychiatrists can prescribe the full range of antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants, and buprenorphine via telemedicine, as long as clinical appropriateness and state PMP checks are met.

How does reimbursement compare: telehealth vs in-person medication management?

For mental health services, reimbursement is generally equal (parity). Medicare pays the same for a 99213 med check whether it’s video or office visit. Most state Medicaid programs and commercial insurers have adopted telehealth parity for behavioral health, especially in states with parity laws (IL, CA, NY). A few states (TX) don’t mandate parity by law, but insurers typically pay equal rates voluntarily due to high demand. NPs get 85% of physician rates under Medicare regardless of modality.

Do I need a separate DEA license for telehealth prescribing?

No separate ‘telehealth DEA license’ exists. You need a DEA registration in the state where the patient is located when you prescribe controlled substances. If you’re treating patients in multiple states via telehealth, you need a DEA registration for each state (plus state medical/nursing licensure). The Interstate Medical Licensure Compact (IMLC) helps physicians get multi-state licenses faster — TX, PA, and IL are members; CA, FL, and NY are not.

What’s the difference between collaborative practice agreements and physician supervision for NPs?

Collaborative practice agreements (in ‘reduced practice’ states like PA or early-career NY/IL) are written agreements outlining scope of practice, prescriptive authority, and physician oversight requirements (chart review frequency, consultation availability). They’re formal legal documents, often filed with state boards. Physician supervision (in ‘restricted practice’ states like TX) goes further — it means the NP is practicing under delegated physician authority for all medical decisions, not just prescribing. In Texas, for example, an NP’s prescription is technically the physician’s prescription being executed by the NP. The NP cannot practice or prescribe independently at any point. Full Practice Authority means neither is required — the NP practices under their own license with no physician involvement.

How often do I need to check the prescription monitoring database?

Depends on your state:

• New York: Must check I-STOP before every controlled substance prescription to a new patient, and at least quarterly for ongoing patients
• California: Required at least once every 4 months for ongoing controlled substance therapy
• Texas, Florida, Pennsylvania, Illinois: Generally require checking before each controlled prescription or at initiation of therapy (check your state-specific statute)

Most telehealth EMR platforms integrate PMP access, making this a quick step during your visit.

Can I use audio-only (phone) for medication management and still get reimbursed?

For mental health services, yes — Medicare and many state Medicaid programs now reimburse audio-only telehealth for behavioral health when video isn’t available. This was extended through 2024–2025 to address the digital divide. You can conduct a brief med management check-in via phone and bill the appropriate E/M code (99213, etc.) at the same rate as office visit, as long as the patient cannot use video. However, for initial evaluations or controlled substance prescriptions, video is typically required to meet the standard of care and state board expectations. Always document why audio-only was used (patient lacked video capability).

What happens if the DEA changes the rules on controlled substance teleprescribing?

The DEA has proposed several rule changes (most recently pushed to late 2024). Potential changes include:

• Requiring a special telemedicine registration
• Limiting initial controlled substance prescriptions via telehealth to 30-day supplies
• Requiring an in-person evaluation within a certain timeframe after initiating controlled substances
• Creating exceptions for referrals from in-person clinicians

If/when new rules are finalized, providers will need to adjust. The psychiatric community has heavily lobbied to maintain access, given the mental health crisis. Most expect some form of permanent telehealth allowance with reasonable guardrails. Subscribe to DEA updates or professional association alerts (APA, AAPP) to stay informed.

The Bottom Line: Telehealth Prescribing Is Here to Stay

If you’re a psychiatrist or PMHNP wondering whether to build a telehealth practice in 2026, the regulatory environment is more favorable than ever:

✅ Psychiatrists have full authority to prescribe nearly all psychiatric medications via telehealth, including controlled substances, under current federal waivers

✅ Payment parity is standard for mental health telehealth across most payers

✅ State scope-of-practice laws are trending toward NP independence, with over half of states now allowing full practice authority (though TX, FL, PA remain restricted)

✅ Patient demand is extraordinary — mental health provider shortages affect every state, with millions of Americans unable to access care

The question isn’t whether telehealth prescribing is viable — it’s whether you want to spend 6–12 months gambling on DIY marketing (at $3,000–5,000/month) or plug into a platform that delivers qualified patients from day one.

Platforms like Klarity Health handle the patient acquisition, credentialing, and infrastructure. You focus on what you’re trained to do: evaluating patients, managing medications, and providing quality psychiatric care.

No upfront marketing spend. No wasted ad budget. You pay only when qualified patients book with you.

For providers in states with collaborative practice requirements, Klarity can also provide physician oversight infrastructure, removing barriers to entry.

Ready to see how Klarity’s provider network works? Explore the platform and see if it’s the right fit for scaling your psychiatric telehealth practice without the patient acquisition headache.

References & Citations

1. Texas Board of Nursing – APRN Practice FAQ. Revised 2021. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html (Primary source for TX NP collaboration requirements)

2. Florida Statutes Chapter 464.012 & 456.47 (2024) – Nursing Practice Act and Telehealth Controlled Substances. Available at: https://www.flsenate.gov/laws/statutes/2024/464.012 (Primary legal text for FL NP scope and telehealth permissions)

3. California Board of Registered Nursing – AB 890 Implementation FAQs. Updated November 2023. Available at: https://www.rn.ca.gov/practice/ab890.shtml (Official state guidance on 103/104 NP categories

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship